Subtle abnormalities in kidney function—even within the range considered normal—may help identify people at risk of ...

Major differences between eGFR based on cystatin C compared with creatinine were associated with higher rates for all-cause mortality, CV events and kidney failure for outpatients, according to data ...

Subtle abnormalities in kidney function – even within the range considered normal – may help identify people at risk of ...

Researchers at Karolinska Institutet have discovered that even slight abnormalities in kidney function—within the normal ...

First randomized Phase III trial confirming the efficacy of MET inhibition in patients with advanced NSCLC and acquired MET amplification after progression on prior EGFR-TKI treatment - ...

Reports positive early clinical experience from first and only clinically validated, extracellular protein degraders using ...

(Alliance News) - Hutchmed China Ltd on Wednesday said the results from its SACHI phase-three lung cancer trial have been published in medical journal the Lancet.

Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 months Notable responses were ...

Summit Therapeutics Inc. ("Summit," "we," or the "Company") today announced that it has submitted a Biologics License ...